Recently, the 2022 China Medical Development conference hosted by the Chinese Academy of Medical Sciences was held in Beijing. At the meeting, the Chinese Academy of Medical Sciences released 31 important medical advances in China in 2021. These medical advances come from biomedical engineering and information, clinical medicine, Stomatology, basic medicine and biology, pharmacy, health and environment and other fields.
Academician Wang Chen, vice president of the Chinese Academy of engineering, President of the Chinese Academy of Medical Sciences, member of the academic department of the Chinese Academy of Medical Sciences and chairman of the Academic Advisory Committee, made a keynote speech
31 medical advances include: the synthetic artificial cornea made of pure artificial materials developed and produced by our company (Beijing Mihe Medical Devices Co., Ltd.) has been approved, the goal of reducing blood pressure in elderly patients with hypertension has been established, the role of skin fibroblasts in the pathogenesis of vitiligo has been found, the detection of high-risk HPV is more suitable for the preliminary screening of cervical cancer in China, the cholesterol absorption inhibitor Haibo Maibu tablets has been approved It is proved that short-term NO2 exposure can increase the risk of death.
China's important medical progress in 2021 focuses on the medical science and technology progress that has certain academic and social influence, promotes discipline development, improves the practice of "promoting prevention, diagnosis, control and health", and promotes the progress potential of the health industry.
Source: News Center of Chinese Academy of Medical Sciences
Take the pure artificial material synthetic cornea designed, developed and produced by our company as an example. Before the product is approved, it has gone through a series of steps, such as technology research and development, process confirmation, physical and chemical performance testing, registration and inspection by national authorities, animal experiments, clinical trials and so on. It takes 24 years. It is the world's first pure artificial material synthetic cornea, which alleviates the current situation of scarce corneal donors in China, and plays an important role in the blindness relief treatment of high-risk patients, It provides an important basis for the research and development of artificial cornea.
The selection of important medical progress in China in 2021 adopts the classification evaluation method combining "diversified measurement indicators" and "multi-agent research and judgment", and includes multi-source data without bias, including medical research papers published by Chinese researchers in 2021, authorized international patents, domestic drug products approved for listing, and domestic innovative medical device products approved for registration. A total of more than 276000 pieces of data are collected as the basic data for selection.
The research team conducted quantitative analysis, expert evaluation and comprehensive research and judgment, formed 77 options, which were recommended by the members of the school department, reviewed by the audit committee and reviewed by the Executive Committee, and finally produced 31 important annual progress.